Michael Korn
Impact in
-
- Cancer Treatment and Pharmacology
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
Papers in
- Oncology 15
- Colorectal Cancer Treatments and Studies 7
- Cancer Treatment and Pharmacology 6
- Cancer Immunotherapy and Biomarkers 2
- Pancreatic and Hepatic Oncology Research 2
-
- Lung Cancer Treatments and Mutations 2
- Co-authors
- S. Seeber (5 shared papers)Wilfried Eberhardt (4 shared papers)U. Klaassen (5 shared papers)Dirk Strumberg (3 shared papers)H. Wilke (4 shared papers)Alan P. Venook (1 shared paper)J. Uy (1 shared paper)Emily K. Bergsland (1 shared paper)
- Journals
- Journal of Clinical Oncology (5 papers)European Journal of Cancer (2 papers)BMC Urology (1 paper)Anti-Cancer Drugs (1 paper)Oncogene (1 paper)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Michael Korn
18 papers receiving 248 citations
Peers
Comparison fields: 5 of 43
- Oncology 166
- Cancer Research 37
- Neurology 36
- Reproductive Medicine 19
- Pulmonary and Respiratory Medicine 62
Countries citing papers authored by Michael Korn
This map shows the geographic impact of Michael Korn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Korn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Korn more than expected).
Fields of papers citing papers by Michael Korn
This network shows the impact of papers produced by Michael Korn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Korn. The network helps show where Michael Korn may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Korn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 60 | |
| 2 | 2008 | 42 | |
| 3 | 2001 | 24 | |
| 4 | Who gets radiotherapy? | 1990 | 22 |
| 5 | 1996 | 20 | |
| 6 | 2012 | 14 | |
| 7 | 1998 | 14 | |
| 8 | 2021 | 12 | |
| 9 | Weekly infusional 5-fluorouracil plus/minus other drugs for the treatment of advanced gastric cancer. | 1996 | 12 |
| 10 | 2018 | 9 | |
| 11 | 1996 | 6 | |
| 12 | 1995 | 6 | |
| 13 | 2018 | 5 | |
| 14 | 2013 | 3 | |
| 15 | Emotionally and practically supporting those attending a radiotherapy department and radiographers working with them. | 1990 | 2 |
| 16 | Infusional 5-FU, folinic acid, paclitaxel, and cisplatin for metastatic breast cancer. | 1997 | 2 |
| 17 | 2018 | 2 | |
| 18 | 2020 | 1 |
About Michael Korn
Michael Korn is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Public Health, Environmental and Occupational Health and Surgery, having authored 18 papers that have together received 256 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (7 papers), Cancer Treatment and Pharmacology (6 papers), Chemotherapy-related skin toxicity (2 papers), Ovarian cancer diagnosis and treatment (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cancer Genomics and Diagnostics (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). The work is most often cited by research in Oncology (166 citations), Cancer Research (37 citations), Neurology (36 citations), Reproductive Medicine (19 citations) and Pulmonary and Respiratory Medicine (62 citations). Michael Korn has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include S. Seeber, Wilfried Eberhardt, U. Klaassen, Dirk Strumberg, H. Wilke, Alan P. Venook, J. Uy, Emily K. Bergsland, Amy Ko and Thomas Weber. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, BMC Urology, Anti-Cancer Drugs and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.